BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, offered at an outstanding value, manufactured in our state-of-the-art facility in San Diego, CA.
Our product areas include cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies. All of BioLegend’s reagents are supported by superior customer service and come with a quality guarantee. Our aggressive product development program, through technology licensing, collaborations, and internal hybridoma development, produces strategic reagents for use in a variety of applications including flow cytometry, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays. BioLegend offers the broadest selection of fluorochrome conjugates for multi-color flow cytometry. With an experienced biochemistry team, BioLegend is well positioned to offer a wide range of custom conjugation services to meet our customers’ specific needs.
Incorporated in June 2002, BioLegend is located in San Diego, in the midst of one of the nation’s largest and fastest growing biotechnology clusters.
Gene Lay, DVM - Founder and CEO
• Co-founder of PharMingen, now BD Biosciences
Brad Kraft – President
• Co-founder of PharMingen
• 20+ years working in the biotechnology industry in R&D, Global Marketing, Business/Corporate Development and M&A
Kent Johnson - Chief Financial Officer
• Former CFO of PharMingen, now BD Biosciences
• 17 years reagents manufacturing experience, broad ERP and M&A experience, California licensed CPA
Nan Jiang, Ph.D. - Vice President of Operations
• Formerly the Process Development Manager at PharMingen
• 20 years extensive experience in organic chemistry and protein chemistry
Xifeng Yang, M.D. - Senior Director of Cell Analysis
• 20 years research and development experience in immunology, hematology, and cell biology.
Shaoquan Ji, DVM/Ph.D. - Vice President of Biomarkers and Immunoassays
• Conducted the development and commercialization of multiplex biomarker immunoassays at LINCO Research/MILLIPORE Corp. using Luminex xMAP technology
• 25 years experience in the areas of nutrition, physiology, protein chemistry and molecular biology
Nancy Huang - Senior Director of International Distribution
BioLegend Japan KK, in partnership with Tomy Digital Biology Co., Ltd., opened in Tokyo in February 2008. Yoshiro Namai, President, and Yoko Yano, Marketing and Business Development Manager, lead a highly experienced and trained technical staff, providing immediate access to BioLegend’s entire portfolio of reagents and the highest level of customer service and technical support.
BioLegend strives to provide quality research reagents and expert technical support to the scientific community worldwide. We look forward to serving your research needs and becoming your long term research partner. We welcome your feedback and suggestions to better serve the research community at large.
|
